Analyst
H.C. Wainwright
Equibles does not estimate personal net worth.
Patrick Trucchio is recorded as Analyst at H.C. Wainwright. Patrick Trucchio has spoken on 9 earnings calls and 5 other investor events across 9 companies, most recently for Silence Therapeutics plc on September 15, 2026. Those appearances were for COMPASS Pathways plc (CMPS), Vir Biotechnology, Inc. (VIR), NRX Pharmaceuticals, Inc. (NRXP), Silence Therapeutics plc (SLN), Alto Neuroscience, Inc. (ANRO) and 4 other companies. The companies whose calls Patrick Trucchio spoke on are classified in the Healthcare sector.
“Good afternoon, and welcome back to H.C. Wainwright's 28th Annual Global Investment Conference. I'm Patrick Trucchio, a Senior Healthcare Analyst at H.C. Wainwright, and it's my pleasure to welcome our next speaker, Steve Romano, EVP of Research and Development at Silence Therapeutics.”
“Good afternoon, and welcome back to H.C. Wainwright's 20th Annual Global Investor Conference held on September 14th of 16th, 2026. I'm Patrick Trucchio, Senior Healthcare Analyst at H.C. Wainwright.”
“Hello, everyone, and welcome back to H.C. Wainwright's 28th Annual Global Investment Conference held on September 14th to 16th, 2026. My name is Patrick Trucchio.”
“Hello, everyone, and good afternoon, and welcome back to the H.C. Wainwright 20th Annual Global Investment Conference. I'm Patrick Trucchio, Senior Healthcare Analyst at H.C. Wainwright.”
“And then just on the reclaim, if I can add a few additional follow-ups, Just in terms of durability of the AUD effect, do you have any sense of whether the treatment effect was early and durable, and will you eventually have this data?”
H.C. Wainwright
Analyst
Source not stated
CMPS
Medical Care Facilities · Healthcare
ALT
Biotechnology · Healthcare
HELP
Biotechnology · Healthcare
